Abstract
We conducted a tandem autologous stem cell transplantation procedure for patients with relapsed or refractory high-grade non-Hodgkin's lymphoma (HGNHL) or with transformation of indolent lymphoma (n=15). These patients had poor prognosis factors. The procedure was well tolerated, ten patients were in complete remission. Overall survival rate is 67%.
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
-
Female
-
Hematopoietic Stem Cell Transplantation* / methods
-
Hematopoietic Stem Cell Transplantation* / mortality
-
Humans
-
Lymphoma, Non-Hodgkin / mortality
-
Lymphoma, Non-Hodgkin / therapy*
-
Male
-
Middle Aged
-
Pilot Projects
-
Prognosis
-
Prospective Studies
-
Remission Induction
-
Salvage Therapy
-
Survival Analysis
-
Transplantation, Autologous / methods
-
Transplantation, Autologous / mortality